Zimmer Biomet Holdings (ZBH) Depreciation & Amortization (CF) (2009 - 2026)

Zimmer Biomet Holdings' Depreciation & Amortization (CF) history runs 18 years deep, the most recent figure standing at $270.0 million for Q1 2026.

• On a quarterly basis, Depreciation & Amortization (CF) rose 6.13% year-over-year to $270.0 million in Q1 2026; TTM through Mar 2026 was $1.1 billion, a 9.61% increase from a year earlier, with the FY2025 full-year figure at $1.1 billion, up 9.79% from the prior year.
• Depreciation & Amortization (CF) eased to $270.0 million in Q1 2026 per ZBH's latest filing, from $284.0 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $284.0 million in Q4 2025 and bottomed at $228.5 million in Q4 2022.
• The 5-year median for Depreciation & Amortization (CF) is $241.2 million (2023), against an average of $249.3 million.
• Across the five-year window, Depreciation & Amortization (CF) slipped 2.02% in 2022 and grew 13.03% in 2025, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $228.5 million in 2022, then grew by 5.56% to $241.2 million in 2023, then climbed by 9.29% to $263.6 million in 2024, then rose by 7.74% to $284.0 million in 2025, then decreased by 4.93% to $270.0 million in 2026.
• Per Business Quant, the three latest ZBH Depreciation & Amortization (CF) figures stand at $270.0 million (Q1 2026), $284.0 million (Q4 2025), and $283.6 million (Q3 2025).